The pharmaceutical industry is undergoing a period of intense transformation, shaped by rapid technological progress, evolving patient expectations, and increasing global competition. Companies today are being pushed to rethink not only how they innovate, but how they operate and grow in a highly regulated environment.
In this ever-changing environment, the need to be able to balance legacy and forward-looking strategy is more important than ever. Agility, execution, and long-term vision are key to sustained success today.
Sami Kiresepi, CEO of Santa Farma Pharmaceuticals, represents this new generation of leadership. As a third-generation leader, he is guiding the company through a phase of global ambition while reinforcing its foundational values. His approach reflects a careful alignment of heritage and transformation, positioning Santa Farma for its next chapter of international relevance and impact.
Let’s explore how Sami is guiding Santa Farma through its next chapter of growth!
A Journey Built on Responsibility and Perspective
Born in Istanbul in 1979, Sami’s journey is closely intertwined with the evolution of Santa Farma itself. The company was always more than a business for his family. It represented responsibility, resilience, and a long-term commitment to healthcare.
Rather than entering the family business immediately, he chose a path that would allow him to build an independent professional foundation. After completing his education in the United States, he began his career at an international pharmaceutical company. The decision was intentional. He wanted to gain an independent perspective, understand different corporate cultures, and build his own professional foundation before joining Santa Farma.
In 2006, he entered the company and worked across multiple functions, including Product Management and Strategic Planning. These experiences provided him with a broad understanding of the pharmaceutical industry, not only from a commercial perspective, but also operationally, strategically, and from a patient-focused perspective.
The culmination of that journey came in 2024 when he assumed the role of CEO. Reflecting on the significance of the position, he explains that “This role represents both continuity and transformation: protecting the values and entrepreneurial spirit that built the company over the past 80 years while preparing Santa Farma for its next phase of global growth.”
Today, his ambition is clear: to transform Santa Farma from a strong Turkish pharmaceutical company into a globally recognized healthcare brand originating from Türkiye.
Leading with Clarity, Accountability, and Long-Term Thinking
As CEO, Sami’s responsibilities extend far beyond overseeing daily operations. His focus is on ensuring that Santa Farma remains competitive, sustainable, and future-oriented within an increasingly complex global pharmaceutical landscape.
A major part of his role involves shaping long-term strategy, strengthening international presence, and building an organizational culture centered around accountability, execution quality, innovation, and adaptability. Yet, for him, leadership is not only about defining vision.
Leadership, he emphasizes, is equally about creating clarity, making decisions under pressure, and empowering talented individuals across the organization.
On a daily basis, he remains closely engaged with key priorities ranging from manufacturing and research and development to international expansion, operational efficiency, and digital transformation initiatives. The pharmaceutical sector’s unique impact on human health influences every aspect of its decision-making process.
As a result, he approaches leadership with discipline, transparency, and a commitment to long-term thinking, qualities that have become increasingly important in an industry where every decision carries lasting consequences.
Balancing Heritage with Transformation
Sami describes his leadership style as transparent, collaborative, and transformation-oriented. At its core is a belief that sustainable success comes from strong teams, clear accountability, and a shared sense of purpose.
In healthcare, where innovation and human impact intersect, he believes leadership requires balancing strategic thinking with genuine understanding. One principle that consistently guides his approach is listening.
As he notes, “Valuable ideas can come from every level of an organization, and creating an environment where people feel heard is essential for innovation and continuous improvement.”
At the same time, he recognizes that leadership also requires decisiveness. In a rapidly changing industry, difficult decisions cannot be avoided. Leaders must act with clarity and responsibility while maintaining confidence in the direction they have chosen.
Another defining principle for him is balancing heritage with transformation. Santa Farma’s deep-rooted values and long-standing legacy remain important strengths, but he believes that enduring success depends on the ability to evolve continuously, adapt to changing realities, and challenge traditional ways of thinking.
Ultimately, his philosophy centers on enabling people rather than controlling them. Leadership, in his view, is about creating the right environment for talented individuals to grow, contribute, and perform at their highest level.
Building Resilience Through Change
Throughout his career, one of the greatest challenges Sami has faced has been leading transformation while preserving the strengths and values of an 80-year-old organization.
The pharmaceutical industry today operates under intense pressure. He explains that rising costs, global competition, regulatory complexity, and rapidly changing market expectations require organizations to become faster, more analytical, and more agile while maintaining the highest quality standards.
One of the most significant lessons he has learned is that growth alone is not enough. Sustainable success requires organizations to improve execution quality continuously, simplify decision-making processes, strengthen accountability, and adapt faster than the pace of market change.
Balancing long-term investment decisions with short-term market realities has also been a recurring challenge. In healthcare, every strategic choice carries operational, financial, and human implications.
These experiences have fundamentally shaped his perspective on resilience. As he explains, resilience is not about reacting emotionally to challenges. Instead, it is about maintaining clarity, discipline, and consistency under pressure while continuing to move forward with purpose.
Driving Competitiveness Through Strategic Investment
For Sami, competitiveness in today’s pharmaceutical industry depends on three critical factors: execution quality, adaptability, and long-term strategic focus.
To strengthen Santa Farma’s position, the company is investing heavily in four key areas: international expansion, advanced manufacturing capabilities, digital transformation, and stronger analytical decision-making.
Building on these investments, the organization is also focused on becoming more agile. Traditional corporate structures often struggle to keep pace with industry changes, and he believes the future belongs to organizations that can respond quickly while maintaining excellence.
At the same time, quality and trust remain non-negotiable. He emphasizes that sustainable growth in pharmaceuticals is only possible when patients, healthcare professionals, and business partners consistently trust a company’s products and standards.
Regulatory excellence is another cornerstone of Santa Farma’s long-term strategy. In line with its international growth objectives, the company continues to strengthen its presence in global markets through its EU GMP, ANVISA GMP, DIGEMID GMP, and EAEU GMP certifications, while also preparing for the Saudi FDA audit scheduled for 2026.
“Our goal is not simply to grow bigger, but to build a globally respected pharmaceutical company originating from Türkiye,” he says.
Innovation Beyond Research and Development
While innovation is often associated exclusively with scientific discovery and research, Sami takes a broader view.
He believes that leaders today must spend less time protecting old models and more time understanding what will reshape the industry over the next decade. To stay ahead of emerging trends, he closely follows global healthcare developments, AI-driven transformation, manufacturing innovation, scientific developments, and evolving patient expectations.
Within Santa Farma, innovation extends far beyond R&D activities. He explains that the organization focuses heavily on improving decision quality, operational efficiency, organizational agility, and execution speed.
One of his key priorities is creating a culture where employees feel encouraged to think critically, challenge assumptions, and contribute ideas that generate meaningful business impact.
In this context, innovation becomes a mindset rather than a department. He firmly believes that in rapidly evolving industries, companies that learn faster and execute better create sustainable competitive advantage.
The Power of Collective Achievement
Throughout Sami’s leadership journey, awards and recognitions have served as meaningful acknowledgments of progress. However, he views them through the lens of collective achievement rather than individual accomplishment.
He believes recognition reflects the dedication, passion, and effort of an entire organization. At the same time, he places greater value on long-term contribution than short-term recognition.
“In healthcare, trust and credibility are built consistently over time,” he emphasizes.
Recognition also reinforces the importance of teamwork, innovation, and remaining committed to strong values while continuing to evolve within a highly dynamic industry. Ultimately, his greatest motivation lies not in awards themselves, but in building an organization that creates sustainable impact for patients, employees, and society.
Creating Sustainable Success Through Balance and Culture
Despite the demands of leading a major pharmaceutical organization, Sami considers maintaining balance an essential part of effective leadership.
The pharmaceutical industry requires constant focus and responsibility, but he believes sustainable leadership is only possible when individuals maintain perspective, energy, and emotional balance. Family plays a particularly important role in helping him remain grounded and recharge outside the intensity of business life.
This perspective also influences how he views organizational culture. He believes companies perform at their best when they support both performance and well-being.
As he explains, “Sustainable success is not created through pressure alone; it is created when people feel motivated, trusted, and connected to a larger purpose.”
By fostering an environment where employees feel valued and empowered, organizations can create the conditions necessary for long-term performance and engagement.
Guidance for the Next Generation of Leaders
Looking at the future of healthcare leadership, Sami encourages aspiring professionals to remain curious, adaptable, and committed to continuous learning.
Given the healthcare industry’s constant evolution and significant responsibilities, he believes building strong expertise while understanding the broader impact of one’s work is essential. Leadership, however, cannot be developed through knowledge alone.
Experience plays a crucial role. Taking on diverse responsibilities, listening to different perspectives, and stepping outside one’s comfort zone all contribute to meaningful growth.
While technical expertise remains important, he places equal value on integrity, resilience, communication, and emotional intelligence. Most importantly, he encourages future leaders to focus on creating long-term value rather than pursuing short-term success.
In healthcare, trust, consistency, and purpose-driven leadership continue to make the greatest difference over time.
Shaping the Next Era of Santa Farma
Looking ahead, Sami’s ambitions for Santa Farma are both ambitious and purposeful. The company aims to become a globally recognized pharmaceutical brand built on quality, trust, innovation, and sustainable growth.
He believes the future belongs to organizations that successfully combine strong heritage with global vision, operational excellence, and adaptability. Acceptance into the TURQUALITY program has already marked an important milestone, supporting Santa Farma’s efforts to strengthen its global positioning and international competitiveness.
Over the coming years, he explains that the company will continue investing in international expansion, advanced manufacturing, digital transformation, and innovation-driven healthcare solutions. Talent development and organizational transformation will remain central to that strategy.
Personally, his goal is to guide Santa Farma into its next era while preserving the entrepreneurial spirit, long-term perspective, and values that have defined the organization for more than 80 years.
For him, leadership extends beyond business growth. It is about building an institution capable of creating meaningful impact for future generations. As he reflects on the responsibility of leadership, his vision is clear: “For me, leadership is not only about growing a business; it is about building an institution that can continue creating meaningful impact for future generations, both in Türkiye and globally.”
That commitment to balancing heritage with transformation, and ambition with responsibility, continues to define Sami Kiresepi’s leadership journey as he guides Santa Farma toward a new era of global growth and lasting healthcare impact.
